REFERENCES
- Hollister, L. E.: Complications from the use of tranquilizing drugs. New England J. Med. 257:170 (July 25) 1957.
- Kinross-Wright, V. and Mover, J. H.: Chlorpromazine and hepatic function. A. M. A. Arch. Neurol. & Psychiat. 76:675 (December) 1956.
- Moyer, J. H., Pevey, K. and Kinross-Wright, V.: Tranquilizing (ataractic) agents: Current evaluation of their clinical use in patients who are not hospitalized. GP 15:97 (June) 1957.
- Fiore, J. M. and Noonan, F. M.: Agranulocytosis due to mepazine (phenothiazine). New England J. Med. 260:375 (February 19) 1959.
- Brachman, P. S., McCreary, T. W. and Florence, R.: Agranulocytosis induced by trimeprazine. New England J. Med. 260:378 (February 19) 1959.
- Delay, J., Deniker, P. and Pauweis, R.: Clinical trial of methoxypromazine; comparison with chlorpromazine. Pearl River, New York, Lederle Laboratories Division, American Cyanamid Company.
- Courvoisier, S., Ducrot, R., Fournel, J. and Jolou, L.: Propriétés pharmacodynamique de la méthopromazine, nouveau neuroleptique apparenté à la chlorpromazine. Compt. rend. Soc. de biol. 15:689, 1957.
- Moyer, J. H., Pevey, K., Heider, C. H. and Kinross-Wright, V.: Comparative study of four tranquilizing agents, phenobarbital, and inert placebo. Geriatrics 13:153 (March) 1958.
- Methoxypromazine. Pearl River, New York, Lederle Laboratories Division, American Cyanamid Company, 1957.